Lipodystrophy Panel
Use
The Lipodystrophy Panel is designed for individuals with relevant features of lipodystrophy or those with atypical or complex presentations that do not fit classic categories. It aids in the diagnosis by identifying genetic variants in 29 genes associated with lipodystrophy.
Special Instructions
For precise diagnosis, it's recommended to provide detailed clinical information and family history. The test is processed by PreventionGenetics, adhering to CLIA and CAP regulations.
Limitations
Potential limitations include the inability to detect low-level mosaicism, variants outside the examined regions, or deep intronic changes. Although the panel covers 29 genes, not all variants may be clinically significant or actionable. Interpretation may depend on the quality of clinical information provided.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided